Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00934414 · ClinicalTrials.gov registry record · Phase 2
Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes
A Phase 2 study, sponsored by Mannkind Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00934414 is a Phase 2 study that has completed, run by Mannkind Corporation. The registered enrollment target is 24 participants.
The verdict
NCT00934414, a Phase 2 study, has completed, sponsored by Mannkind Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitus will be enrolled in this study to determine the effect of Technosphere® Insulin Inhalation Powder on insulin in the body during a clamp procedure.
Interventions
- DRUG Technosphere Insulin Inhalation Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00934414
The ClinicalTrials.gov registry entry for NCT00934414 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mannkind Corporation, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Technosphere Insulin Inhalation Powder is the first listed.
NCT00934414 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00934414 about?
NCT00934414 is a clinical study titled "Clamp Study Comparing Inhalation of Technosphere®/Insulin in Smokers and Non-Smokers With Type 2 Diabetes". Twelve smoking and twelve non-smoking subjects with Type 2 Diabetes Mellitus will be enrolled in this study to determine the effect of Technosphere® Insulin Inhalation Powder on insulin in the body during a clamp procedure.
What is the current status of trial NCT00934414?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2004-08. Estimated completion is 2006-09.
What interventions are being tested in trial NCT00934414?
The interventions under investigation include: Technosphere Insulin Inhalation Powder (DRUG).
Who is sponsoring clinical trial NCT00934414?
This trial is sponsored by Mannkind Corporation, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.